121 related articles for article (PubMed ID: 22952737)
21. Formation of DNA adducts by ellipticine and its micellar form in rats - a comparative study.
Stiborova M; Manhartova Z; Hodek P; Adam V; Kizek R; Frei E
Sensors (Basel); 2014 Dec; 14(12):22982-97. PubMed ID: 25479328
[TBL] [Abstract][Full Text] [Related]
22. Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent.
Liu J; Zeng F; Allen C
J Control Release; 2005 Mar; 103(2):481-97. PubMed ID: 15763628
[TBL] [Abstract][Full Text] [Related]
23. Effect of phospholipid bilayers on solution conformation of branched polymeric polypeptides and peptide-polymer conjugates.
Nagy IB; Majer Z; Hudecz F
Biopolymers; 2001 Feb; 58(2):152-64. PubMed ID: 11093114
[TBL] [Abstract][Full Text] [Related]
24. Formation of colloidal suspension of hydrophobic compounds with an amphiphilic self-assembling peptide.
Fung SY; Yang H; Chen P
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):200-11. PubMed ID: 17234393
[TBL] [Abstract][Full Text] [Related]
25. A peptide-based material platform for displaying antibodies to engage T cells.
Zheng Y; Wen Y; George AM; Steinbach AM; Phillips BE; Giannoukakis N; Gawalt ES; Meng WS
Biomaterials; 2011 Jan; 32(1):249-57. PubMed ID: 20880580
[TBL] [Abstract][Full Text] [Related]
26. Partitioning of prototropic species of an anticancer drug ellipticine in bile salt aggregates of different head groups and hydrophobic skeletons: a photophysical study to probe bile salts as multisite drug carriers.
Thakur R; Das A; Adhikari C; Chakraborty A
Phys Chem Chem Phys; 2014 Aug; 16(29):15681-91. PubMed ID: 24960221
[TBL] [Abstract][Full Text] [Related]
27. Arginine-Modified Nanostructured Lipid Carriers with Charge-Reversal and pH-Sensitive Membranolytic Properties for Anticancer Drug Delivery.
Sun M; Li J; Zhang C; Xie Y; Qiao H; Su Z; Oupický D; Ping Q
Adv Healthc Mater; 2017 Apr; 6(8):. PubMed ID: 28187243
[TBL] [Abstract][Full Text] [Related]
28. Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells.
Hrabeta J; Groh T; Khalil MA; Poljakova J; Adam V; Kizek R; Uhlik J; Doktorova H; Cerna T; Frei E; Stiborova M; Eckschlager T
Int J Oncol; 2015 Sep; 47(3):971-80. PubMed ID: 26134421
[TBL] [Abstract][Full Text] [Related]
29. An amphipathic lytic peptide for enhanced and selective delivery of ellipticine.
Lu S; Ding Y; Wu Y; Wang R; Pan R; Wan Z; Xu W; Zhang L; Yuan YF; Chen P
J Mater Chem B; 2016 Jun; 4(24):4348-4355. PubMed ID: 32263417
[TBL] [Abstract][Full Text] [Related]
30. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy.
Ranjan AP; Mukerjee A; Helson L; Vishwanatha JK
J Nanobiotechnology; 2012 Aug; 10():38. PubMed ID: 22937885
[TBL] [Abstract][Full Text] [Related]
31. Preparation of pH-responsive polymer core-shell nanospheres for delivery of hydrophobic antineoplastic drug ellipticine.
Wang H; Yang L; Rempel GL
Macromol Biosci; 2014 Feb; 14(2):166-72. PubMed ID: 24106137
[TBL] [Abstract][Full Text] [Related]
32. Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics.
Gupta L; Sharma AK; Gothwal A; Khan MS; Khinchi MP; Qayum A; Singh SK; Gupta U
Int J Pharm; 2017 Aug; 528(1-2):88-99. PubMed ID: 28533175
[TBL] [Abstract][Full Text] [Related]
33. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.
Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y
Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier.
Zhao X; Zhao Y; Geng L; Li X; Wang X; Liu Z; Wang D; Bi K; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(31):3721-7. PubMed ID: 22035980
[TBL] [Abstract][Full Text] [Related]
35. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of 10-hydroxycamptothecin-tetrandrine liposome complexes in rat by a simple and sensitive ultra-high performance liquid chromatography with tandem mass spectrometry.
Shuang R; Wang M; Mao J; Zou J; Ping Y
J Sep Sci; 2020 Feb; 43(3):569-576. PubMed ID: 31701613
[TBL] [Abstract][Full Text] [Related]
37. Ionically fixed polymeric nanoparticles as a novel drug carrier.
Lee SW; Chang DH; Shim MS; Kim BO; Kim SO; Seo MH
Pharm Res; 2007 Aug; 24(8):1508-16. PubMed ID: 17380262
[TBL] [Abstract][Full Text] [Related]
38. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
39. Monitoring uptake of ellipticine and its fluorescence lifetime in relation to the cell cycle phase by flow cytometry.
Sailer BL; Valdez JG; Steinkamp JA; Darzynkiewicz Z; Crissman HA
Exp Cell Res; 1997 Oct; 236(1):259-67. PubMed ID: 9344606
[TBL] [Abstract][Full Text] [Related]
40. Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting.
Bragagni M; Mennini N; Ghelardini C; Mura P
J Pharm Pharm Sci; 2012; 15(1):184-96. PubMed ID: 22365096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
